Predict your next investment

Angel Investor (Individual)
imaftriad.com

See what CB Insights has to offer

Investments

17

Portfolio Exits

1

About IMAF-Triad

MAF Triad is part of the Inception Micro Angel Fund Family of Funds , which is a group of member-managed seed stage angel capital funds designed to capitalize on the growth in entrepreneurial activity and venture financing, throughout the state of North Carolina and in selective areas of Virginia, South Carolina, Georgia and Tennessee.IMAF is a member-owned and member-managed limited liability company, organized to provide members an opportunity for active involvement in a diversified capital investment process.

IMAF-Triad Headquarter Location

1959 N. Peace Haven Road, #111

Winston-Salem, North Carolina, 27106,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

IMAF-Triad Investments

17 Investments

IMAF-Triad has made 17 investments. Their latest investment was in School House as part of their Convertible Note on August 8, 2012.

CBI Logo

IMAF-Triad Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/25/2012

Convertible Note

School House

$0.34M

Yes

3/3/2011

Unattributed VC

Bioptigen

$1.5M

No

8/17/2006

Series A

Bioptigen

$1.3M

Yes

6/13/2005

Angel

Subscribe to see more

$99M

Subscribe to see more

0

8/13/2004

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/25/2012

3/3/2011

8/17/2006

6/13/2005

8/13/2004

Round

Convertible Note

Unattributed VC

Series A

Angel

Unattributed VC

Company

School House

Bioptigen

Bioptigen

Subscribe to see more

Subscribe to see more

Amount

$0.34M

$1.5M

$1.3M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

IMAF-Triad Portfolio Exits

1 Portfolio Exit

IMAF-Triad has 1 portfolio exit. Their latest portfolio exit was Bioptigen on June 02, 2015.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/2/2015

Acquired

$99M

1

Date

6/2/2015

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.